阿尔茨海默病:一个适合精准医学治疗的病例?
概括
早期发现阿尔茨海默病 (AD) 是关键的,因为治疗在临床前阶段最有效. 精准医学和新型疗法,如反意义分子和基因编辑,有望阻止或逆转阿尔茨海默病的进展.
科学领域:
- 神经科学是一个神经科学.
- 老年病的医生 老年病的医生
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是老年人神经退行的主要原因.
- 临床症状包括记忆丧失,混乱和行为变化.
- 通过生物标志物的早期AD检测是可能的,在临床前阶段治疗疗效最高.
研究的目的:
- 审查阿尔茨海默病 (AD) 治疗的最新进展.
- 探索精准医学在定制AD治疗中的作用.
- 讨论针对AD进展的新型治疗策略.
主要方法:
- 关于AD生物标志物和治疗点的当前文献的综述.
- 分析新兴的治疗方式,包括抗意义分子,抗体,抗氧化剂,小分子和基因编辑.
- 探索用于患者分层的精准医学方法.
主要成果:
- 药物治疗在阿尔茨海默病的临床前阶段最有效,即症状出现前15-20年.
- 精准医学提供了一个平台,根据各种参数对AD患者进行分类.
- 新的治疗策略旨在阻止或潜在地逆转AD的进展.
结论:
- 目前AD治疗的发展重点是早期干预和疾病修改.
- 精准医学对于AD个性化治疗策略至关重要.
- 新兴疗法显示出可能对阿尔茨海默病进展和结果产生重大影响的潜力.
相关概念视频
Alzheimer's Disease: Treatment
188
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
188
Alzheimer's Disease: Overview
481
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
481
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113


